![Theo van der Leij](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Theo van der Leij
Direttore operativo presso PamGene BV
Profilo
Theo van der Leij currently works at PamGene International BV, as Chief Operating Officer and PamGene BV, as Chief Operating Officer.
Mr. van der Leij also formerly worked at Organon Teknika BV, as Manufacturing Manager.
Mr. van der Leij received his graduate degree from Delft University of Technology.
Posizioni attive di Theo van der Leij
Società | Posizione | Inizio |
---|---|---|
PamGene BV
![]() PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Direttore operativo | - |
PamGene International BV
![]() PamGene International BV Pharmaceuticals: MajorHealth Technology PamGene is a biomarker company, focused on opening up new opportunities for the development of Personalized Medicine (pre-clinical, translational and clinical). Most of PamGene's projects are in oncology and many of these involve medicines that inhibit or modulate cellular kinases and kinase pathways. The firm collaborators apply its technologies for biomarker research in several other diseases and fields of expertise such as the Central Nervous System, the Cardiovascular area, Immunology and Obesity. PamGene's technology offers a faster and lower risk route for discovery and development of clinically useful biomarkers and uses cell lines and retrospective patient sample collection testing. | Direttore operativo | - |
Precedenti posizioni note di Theo van der Leij
Società | Posizione | Fine |
---|---|---|
Organon Teknika BV
![]() Organon Teknika BV Medical SpecialtiesHealth Technology Organon Teknika BV manufactures HIV diagnostic products, including NucliSens HIV-1 viral load and nucliSens HIV-1 RNA detection assays. The company is headquartered in Boxtel, the Netherlands. | Corporate Officer/Principal | - |
Formazione di Theo van der Leij
Delft University of Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
PamGene BV
![]() PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Health Technology |
PamGene International BV
![]() PamGene International BV Pharmaceuticals: MajorHealth Technology PamGene is a biomarker company, focused on opening up new opportunities for the development of Personalized Medicine (pre-clinical, translational and clinical). Most of PamGene's projects are in oncology and many of these involve medicines that inhibit or modulate cellular kinases and kinase pathways. The firm collaborators apply its technologies for biomarker research in several other diseases and fields of expertise such as the Central Nervous System, the Cardiovascular area, Immunology and Obesity. PamGene's technology offers a faster and lower risk route for discovery and development of clinically useful biomarkers and uses cell lines and retrospective patient sample collection testing. | Health Technology |
Organon Teknika BV
![]() Organon Teknika BV Medical SpecialtiesHealth Technology Organon Teknika BV manufactures HIV diagnostic products, including NucliSens HIV-1 viral load and nucliSens HIV-1 RNA detection assays. The company is headquartered in Boxtel, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Theo van der Leij